Documento fuente o registro público

Commercially Distributed Analyte Specific Reagents (ASRs): Frequently Asked Questions

FDA question-and-answer guidance about commercially distributed analyte specific reagents. Consult the original document and current FDA notices for applicable requirements.

Technical guidanceU.S. Food and Drug Administration

Fuente

This guidance document refers to commercially distributed ASRs and the term "manufacturer" refers to manufacturers of commercially distributed ASRs.
fda.gov · Consultado el 2026-10-19

Esta entrada describe lo que cubre el documento; el propio documento es la autoridad. Incluirlo no implica estar de acuerdo con sus conclusiones.

Review and references

Reviewer

Automated source verification

Published

2026-10-18

Updated

2026-10-20

Disclaimer

professional use

References

Commercially Distributed Analyte Specific Reagents (ASRs): Frequently Asked Questions

Interested in these solutions?

Submit a sourcing request with the assays, volumes, and timeline of your own project.

Solicitar cotización

Explorar más

Misma fuente

Oncology Drug Products Used with Certain In Vitro Diagnostic Tests: Pilot Program

FDA source page describing its voluntary pilot program for selected oncology drugs used with in vitro diagnostic tests; participation and current status must be checked with FDA.

Misma fuente

Developing and Labeling In Vitro Companion Diagnostic Devices for a Specific Group of Oncology Therapeutic Products

FDA guidance on development and labeling considerations for companion diagnostics intended to support a group of oncology therapeutic products.

Misma fuente

Statistical Guidance on Reporting Results from Studies Evaluating Diagnostic Tests

FDA source document on reporting diagnostic test study results, including the choice of comparison standard and measures of test performance.